Adaptin Bio, Inc
Adaptin Bio, Inc., based in Charlotte, NC, is at the forefront of developing innovative therapeutics aimed at delivering treatments directly to the brain and other targeted tissues. Their pioneering BRiTE technology, which utilizes a unique combination of T cell engagers and manipulated polyclonal T cells, has demonstrated promising efficacy in preclinical studies against various malignant glioma cell lines.
The company addresses critical medical needs across multiple high-value markets, including oncology, central nervous system disorders, autoimmune diseases, and cardiovascular conditions. Collaborating with leading scientists and experts, Adaptin Bio is committed to advancing its groundbreaking medical breakthroughs toward commercialization.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
